Shared decision-making: A practical guide for treatment of eosinophilic esophagitis
Journal of Food Allergy · 01.10.2026 · 8 (2) · 103-110
DOI: 10.2500/jfa.2026.8.260021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Food Allergy, erschienen am 01.10.2026. Verfasst von Mirna Chehade. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Background
Eosinophilic esophagitis (EoE) is a chronic immune-mediated esophageal disease that requires long-term management to control symptoms, reduce inflammation, and prevent fibrostenotic complications. Several treatment options are currently available, including dietary elimination strategies, proton-pump inhibitors, swallowed topical corticosteroids, and biologic therapy. However, the absence of large head-to-head comparative trials; variability in patient response; and differences in lifestyle, monitoring, and adherence requirements across treatment options render therapeutic decisions highly preference-sensitive. As a result, shared decision making (SDM) is essential in the management of patients with EoE.
Methods
This narrative review is based on a targeted literature search to identify studies relevant to EoE and SDM. A practical SDM framework for the management of EoE is also presented.
Results
This review provides a practical, evidence-based overview of currently available therapies for EoE in both adults and children, incorporating recent clinical trial data, U.S. Food and Drug Administration approvals, and current guideline recommendations. The efficacy and limitations of dietary and pharmacologic therapies are summarized, with emphasis on histologic outcomes and the practical considerations that influence individualized treatment selection. Emerging biologics and small molecules under investigation are also discussed within the context of the evolving therapeutic landscape. In addition, this review examines patient and provider perspectives on SDM in EoE, highlighting gaps in implementation and opportunities to improve patient engagement and satisfaction. The role of SDM within multidisciplinary care is also emphasized, given the frequent presence of atopic and immune-mediated comorbidities in patients with EoE and the need for coordinated long-term care.
Conclusion
In a chronic disease with multiple viable treatment pathways, SDM enables alignment of therapeutic strategies with patient values, preferences, and life circumstances. Integrating SDM into ongoing routine EoE management supports treatment adherence and has the potential to optimize long-term disease outcomes and overall well-being for patients and their caregivers.
Zitieren
APA
Chehade, M. (2026). Shared decision-making: A practical guide for treatment of eosinophilic esophagitis. Journal of Food Allergy, 8(2), 103-110. https://doi.org/10.2500/jfa.2026.8.260021
Vancouver
Chehade M. Shared decision-making: A practical guide for treatment of eosinophilic esophagitis. Journal of Food Allergy. 2026;8(2):103-110. doi:10.2500/jfa.2026.8.260021
BibTeX
@article{Chehade2026,
author = {Chehade, Mirna},
title = {Shared decision-making: A practical guide for treatment of eosinophilic esophagitis},
journal = {Journal of Food Allergy},
year = {2026},
volume = {8},
number = {2},
pages = {103--110},
doi = {10.2500/jfa.2026.8.260021}
}
EUVIMED